Franklin Biotechnology Discovery Fund Class R6 (FRBRX)
| Fund Assets | 1.02B |
| Expense Ratio | 0.69% |
| Min. Investment | $1,000,000 |
| Turnover | 21.87% |
| Dividend (ttm) | 18.40 |
| Dividend Yield | 10.16% |
| Dividend Growth | 56.47% |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 22, 2025 |
| Previous Close | 181.09 |
| YTD Return | -1.92% |
| 1-Year Return | 45.29% |
| 5-Year Return | 25.73% |
| 52-Week Low | 96.69 |
| 52-Week High | 185.98 |
| Beta (5Y) | n/a |
| Holdings | 89 |
| Inception Date | May 1, 2013 |
About FRBRX
The Franklin Biotechnology Discovery Fund is a mutual fund designed to provide capital appreciation by primarily investing in equity securities of biotechnology companies and discovery research firms. It focuses on capturing growth opportunities in the healthcare sector, particularly among biotechnology innovators. The fund's portfolio typically includes a mix of established large-cap companies and smaller, growth-oriented biotech firms. By concentrating on this niche, the fund plays a significant role in the healthcare investment landscape, allowing investors to tap into the potential of biotechnology advancements. Its investment strategy aligns with the broader NASDAQ Biotechnology Index, reflecting the performance of the biotechnology sector. The fund's role in the financial market is to offer a specialized investment vehicle for those interested in the healthcare industry's biotech segment.
Performance
FRBRX had a total return of 45.29% in the past year, including dividends. Since the fund's inception, the average annual return has been 15.65%.
Top 10 Holdings
40.13% of assets| Name | Symbol | Weight |
|---|---|---|
| Gilead Sciences, Inc. | GILD | 5.31% |
| Jazz Pharmaceuticals plc | JAZZ | 4.70% |
| Regeneron Pharmaceuticals, Inc. | REGN | 4.60% |
| Amgen Inc. | AMGN | 4.58% |
| Vertex Pharmaceuticals Incorporated | VRTX | 4.52% |
| argenx SE | ARGX | 4.02% |
| Praxis Precision Medicines, Inc. | PRAX | 3.32% |
| Insmed Incorporated | INSM | 3.20% |
| Terns Pharmaceuticals, Inc. | TERN | 3.04% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 2.85% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 22, 2025 | $18.4014 | Dec 22, 2025 |
| Dec 20, 2024 | $11.7607 | Dec 20, 2024 |
| Dec 20, 2022 | $0.5857 | Dec 20, 2022 |
| Dec 15, 2021 | $18.2831 | Dec 15, 2021 |
| Dec 15, 2020 | $10.3921 | Dec 15, 2020 |
| Dec 16, 2019 | $14.1643 | Dec 18, 2019 |